Analysed EXELIXIS INC (EXEL:NASDAQ) News Sources
TD Cowen Sees Pipeline Growth Opportunities Supporting Exelixis, Inc. (EXEL) Outlook
11-05-2026
yahoo.com
Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer
19-05-2026
yahoo.com
Assessing Exelixis (EXEL) Valuation After Merck Zanzalintinib Keytruda Colorectal Cancer Collaboration
21-05-2026
yahoo.com
Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types
21-05-2026
yahoo.com
Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near
23-05-2026
marketbeat.com
What is the current price of EXELIXIS INC (EXEL:NASDAQ)?
The current price of EXELIXIS INC (EXEL:NASDAQ) is $50.03.
EXELIXIS INC (EXEL:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXELIXIS INC (EXEL:NASDAQ) since the previous trading day is $0.05.
EXELIXIS INC (EXEL:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXELIXIS INC (EXEL:NASDAQ) since the previous trading day is 0.1%.
What is the most recent average sentiment score for EXELIXIS INC (EXEL:NASDAQ)?
The most recent average sentiment score for EXELIXIS INC (EXEL:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for EXELIXIS INC (EXEL:NASDAQ)?
The most recent sentiment for EXELIXIS INC (EXEL:NASDAQ) is .
SEC-8K** Filing Available For EXELIXIS INC (EXEL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.